VeriMomVeriMom

oleamide hamilelikte güvenli mi?

No harmonised CLP classification or SCCS/CIR reproductive restriction found for cis‑9‑octadecenamide (oleamide, CAS 301‑02‑0) and no human teratogenic/reprotoxic signal in the literature. Animal studies found neuropharmacologic and neonatal supplementation effects after systemic administration, but these do not indicate developmental/teratogenic hazard from topical cosmetic use. ECHA substance information and REACH dossiers list the substance but show no harmonised repro classification. (ECHA substance page; PubMed animal studies). ([echa.europa.eu](https://www.echa.europa.eu/substance-information/-/substanceinfo/100.005.550?utm_source=openai))

İçerikler
oleamide
BILINEN RISK YOK
93
/100
0

Related ingredients

Frequently asked questions

oleamide hamilelikte güvenli mi?
No harmonised CLP classification or SCCS/CIR reproductive restriction found for cis‑9‑octadecenamide (oleamide, CAS 301‑02‑0) and no human teratogenic/reprotoxic signal in the literature. Animal studies found neuropharmacologic and neonatal supplementation effects after systemic administration, but these do not indicate developmental/teratogenic hazard from topical cosmetic use. ECHA substance information and REACH dossiers list the substance but show no harmonised repro classification. (ECHA substance page; PubMed animal studies). ([echa.europa.eu](https://www.echa.europa.eu/substance-information/-/substanceinfo/100.005.550?utm_source=openai))
oleamide emzirirken güvenli mi?
No data indicating oleamide is a breast‑feeding hazard (no human lactation/transfer studies or regulatory flags). Oleamide is an endogenous fatty‑acid amide studied systemically in animals; that literature does not demonstrate reproductive or lactation toxicity that would trigger regulatory classification. Dermal cosmetic use therefore is not flagged, though systemic exposure data are sparse. ([echa.europa.eu](https://www.echa.europa.eu/substance-information/-/substanceinfo/100.005.550?utm_source=openai))
oleamide bebek cildi için güvenli mi?
Hazard and mechanism: no infant‑specific developmental/toxicity evidence found. Exposure: because infants (0–3 y) have a higher surface‑area‑to‑weight ratio and an immature barrier, dermal exposure scoring is increased by +1 versus adults when measurable absorption is plausible. Oleamide is a relatively lipophilic fatty‑acid amide with low aqueous solubility and limited dermal data, so adult exposure scored as low/measurable and infant exposure as moderate. ([echa.europa.eu](https://www.echa.europa.eu/substance-information/-/substanceinfo/100.005.550?utm_source=openai))
VeriMom oleamide nasıl puanlıyor?
VeriMom oleamide'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 93/100 (bilinen risk yok) olarak puanlar.
Hamilelikte oleamide yerine neler kullanılabilir?
Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.

Her etiketi 2 saniyede kontrol et

VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.

Tıbbi Sorumluluk Reddi

Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.

VeriMom uygulamasında tüm özellikleri keşfedin